FREE REPLAY
__

NEW OPNEO AUTHORISATIONS LINKED TO COVID-19:
ARE YOU READY?

OPnEO AUTHORISATION DEADLINES & COVID-19

OPnEO is an endocrine disruptor which has made its entry in Annex XIV of REACH already in 2017, with a latest application date on 4th July 2019 and a sunset date on 4th January 2021.

Whereas most applications for authorisations for OPnEO have therefore already been submitted to the European Chemicals Agency, a new use of OPnEO related to the Covid-19 pandemic has emerged since December 2019.

The European Commission has postponed the latest application date and the sunset date for OPnEO used for medicinal products, medical devices, or accessories to medical devices, including IVD, for the diagnosis, treatment or prevention of COVID-19 to respectively June 2022 and December 2023.

Find out about the European Commission Decision, the conditions linked to this specific Authorisation possibility and the Application for Authorisation process.

 

AGENDA

  • OPnEO main properties of interest for medicinal products, devices or accessories to medical devices
  • New latest application date and sunset date for COVID-19 use of OPnEO
  • Conditions to benefit from those new deadlines
  • Application for Authorisation process

REGISTER NOW TO SEE OUR REPLAY!

Souleymane GAYE
REACH Authorisation & Public affairs consultant

Souleymane has extensive experience as a strategic analysis consultant in the field of business intelligence. He brings his expertise in socio-economic analysis and focuses on regulatory issues related to REACH and authorisation.

Marie DELAFONTAINE
Toxicologist - Immunologist

Marie is the Registration and Authorisation Project Manager. She contributes to the development of risk assessment strategies for the use of Annex XIV substances, the drafting of chemical safety reports (CSRs), and the defence of dossiers before ECHA.

 
© EcoMundo 2020
Follow us on Twitter!Follow us on LinkedIn!